All In Biotech

Drug Trial Radar · NCT02838225

DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer

A Randomized, Phase II Study Comparing DA (Paclitaxel, Pirarubicin) With DAC ( Paclitaxel, Pirarubicin,Cyclophosphamide) as Postoperative Adjuvant Treatment for Early-stage Breast Cancer

Last checked: Nov 20, 2026Latest source record: Jul 20, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Jan 2009

Primary completion

Jan 2016

Sponsor

Lead sponsor
Peking Union Medical College HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 20, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Our study is a prospective, non-inferior, randomized phase II clinical trial, to compare the efficacy and safety profiles of DA versus DAC as adjuvant chemotherapy regimens for early-stage breast cancer patients.

Conditions

  • Breast Cancer

Interventions

  • Docetaxel, DoxorubicinDrug

  • Docetaxel, Doxorubicin, CyclophosphamideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free survivalTime frame: 5 years
  2. Adverse event rate (CTCAE v. 3.0)Time frame: 5 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.